Structural genomics is the systematic determination of 3D structures of proteins representative of the range of protein structure and function found in nature. The goal is to build a body of structural information that will predict the structure and potential function for almost any protein from knowledge of its coding sequence. This is essential information for understanding the functioning of the human proteome, the ensemble of tens of thousands of proteins specified by the human genome.
While most structural biologists pursue structures of individual proteins or protein groups, specialists in structural genomics pursue structures of proteins on a genome wide scale. This implies large-scale cloning, expression and purification. One main advantage of this approach is economy of scale.
*Examines the three dimensional structure of all proteins of a given organism, by experimental methods such as X-ray crystallography and NMR spectroscopy
* Looks at structural genomics as a foundation of drug discovery as discovering new medicines is becoming more challenging and the pharmaceutical industry is looking to new technologies to help in this mission
"synopsis" may belong to another edition of this title.
Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund, UK (renamed after the merger with Cancer Research Campaign to Cancer Research UK, London Research Institute) and Cardiff University. In 2010 Dr. Donev was appointed Lecturer in Swansea University. Currently he is Director of Biomed Consult Ltd, UK. His major research interests include signalling pathways involved in neuropsychiatric disorders and tumour escape from the immune system, and development of therapeutic strategies for treatment. He has published more than 50 research papers, has chaired scientific meetings in Molecular Medicine and given plenary talks at Attention Deficit/Hyperactivity Disorder meetings. Rossen Donev has consulted on projects related to development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of the Advances in Protein Chemistry and Structural Biology and on editorial board of several other journals.
"About this title" may belong to another edition of this title.
Book Description Academic Press 2011-07-12, 2011. Hardcover. Book Condition: New. Bookseller Inventory # NU-ELS-00003765
Book Description Academic Press, 2011. Hardback. Book Condition: NEW. 9780123812629 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Bookseller Inventory # HTANDREE0892713
Book Description Academic Press, 2011. Hardback. Book Condition: NEW. 9780123812629 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. Bookseller Inventory # HTANDREE01196804
Book Description Elsevier. Book Condition: New. pp. 312. Bookseller Inventory # 6266587
Book Description Academic Press, 2011. Hardcover. Book Condition: New. 1. Bookseller Inventory # DADAX0123812623
Book Description Academic Pr, 2011. Hardcover. Book Condition: Brand New. 1st edition. 304 pages. 9.25x6.25x0.75 inches. In Stock. Bookseller Inventory # zk0123812623
Book Description Academic Press, 2011. Hardcover. Book Condition: New. book. Bookseller Inventory # 0123812623